Dagode, Salvacion L.
HRN: 12-71-83 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/09/2023
CEFTAZIDIME 1GM (VIAL)
11/09/2023
11/15/2023
IVTT
1g
Q8
AGE With Mod DHN; UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes